Primary Record
Cucurbitacin A
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,630 g
- Purity
- 99.0 %
- CAS
- 6040-19-3
Compound Identifiers & Properties
- CAS
- 6040-19-3
- PubChem CID
- 5281315
- SMILES
- CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O)CO)C)C)O)O
- Canonical SMILES
- CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(CO)C(=O)C[C@]12C
Names & Synonyms
- Cucurbitacin A
- Cucurbitacine A
- CucurbitacinA
- 6040-19-3
- AC1NQYBS
- RefChem:128712
- UNII-83859MTO77
- NSC 94743
- NSC94743
- NSC-94743
- CHEBI:3940
- CHEMBL455518
- orb1684677
- 83859MTO77
- C32H46O9
- Cucurbitacine A; NSC 94743
- SCHEMBL10307352
- DTXSID801317236
- GAA04019
- HY-N4175
- ZINC4097796
- 9169AF
- LMST01010103
- NP7089
- AKOS040760353
- ACN-057252
- C32-H46-O9
- CID5281315
- FS-6973
- J8.336D
- DA-62530
- LS-96986
- CS-0032364
- C08793
- [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate
- Q27106258
- 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-, (2beta,9beta,10alpha,16alpha,23E)-
- 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-
- [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(
- 19-Norlanosta-5,11,22-trione, 2,16,20,25-tetrahydroxy-9-(hydroxymethyl)-, 25-acetate
- ((E,6R)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta(a)phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl) acetate
- (10alpha,23E)-25-(Acetyloxy)-2beta,16alpha,20-trihydroxy-9beta-(hydroxymethyl)-19-norlanosta-5,23-diene-3,11,22-trione
- (2S,4R,23E)-2,16alpha,20-Trihydroxy-9alpha-(hydroxymethyl)-10,14-dimethyl-1,11,22-trioxo-8beta-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate
- (3E,6R)-6-[(1R,2R,3aS,3bS,8S,9aR,9bR,11aR)-2,8-dihydroxy-9b-(hydroxymethyl)-3a,6,6,11a-tetramethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
- [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate
- 19-Nor-9.beta.,23-diene-3,11,22-trione, 2.beta.,16.alpha.,20,25-tetrahydroxy-9-(hydroxymethyl)-,25-acetate, (E)-
- 19-Norlanosta-5,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-,(2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-